awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55030214-012BCADA-0136-423B-AA82-68E97353B2CA
Q55030214-012BCADA-0136-423B-AA82-68E97353B2CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55030214-012BCADA-0136-423B-AA82-68E97353B2CA
Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer.
P2860
Q55030214-012BCADA-0136-423B-AA82-68E97353B2CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55030214-012BCADA-0136-423B-AA82-68E97353B2CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba9859c980df7dd2bdca532e2a639965a1213ad3
P2860
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)